[go: up one dir, main page]

NO971903L - Krystallisering av levobupivacain og analoger derav - Google Patents

Krystallisering av levobupivacain og analoger derav

Info

Publication number
NO971903L
NO971903L NO971903A NO971903A NO971903L NO 971903 L NO971903 L NO 971903L NO 971903 A NO971903 A NO 971903A NO 971903 A NO971903 A NO 971903A NO 971903 L NO971903 L NO 971903L
Authority
NO
Norway
Prior art keywords
pct
levobupivacaine
analogs
crystallization
sec
Prior art date
Application number
NO971903A
Other languages
English (en)
Other versions
NO971903D0 (no
NO309266B1 (no
Inventor
Marianne Langston
Benjamin Mark Skead
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9421476A external-priority patent/GB9421476D0/en
Priority claimed from GBGB9504926.8A external-priority patent/GB9504926D0/en
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Publication of NO971903L publication Critical patent/NO971903L/no
Publication of NO971903D0 publication Critical patent/NO971903D0/no
Publication of NO309266B1 publication Critical patent/NO309266B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO971903A 1994-10-25 1997-04-24 Fremgangsmåte for fremstilling av optisk anriket bupivacain NO309266B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9421476A GB9421476D0 (en) 1994-10-25 1994-10-25 Process and salt
GBGB9504926.8A GB9504926D0 (en) 1995-03-10 1995-03-10 Crystallisation
PCT/GB1995/002513 WO1996012699A1 (en) 1994-10-25 1995-10-23 Crystallisation of levobupivacaine and analogues thereof

Publications (3)

Publication Number Publication Date
NO971903L true NO971903L (no) 1997-04-24
NO971903D0 NO971903D0 (no) 1997-04-24
NO309266B1 NO309266B1 (no) 2001-01-08

Family

ID=26305863

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971903A NO309266B1 (no) 1994-10-25 1997-04-24 Fremgangsmåte for fremstilling av optisk anriket bupivacain

Country Status (16)

Country Link
US (1) US5994548A (no)
EP (1) EP0788480B1 (no)
JP (1) JP3911545B2 (no)
AT (1) ATE245629T1 (no)
AU (1) AU698637B2 (no)
CA (1) CA2200355C (no)
DE (1) DE69531356T2 (no)
DK (1) DK0788480T3 (no)
ES (1) ES2202375T3 (no)
FI (1) FI117438B (no)
HU (1) HU227420B1 (no)
MX (1) MX9703024A (no)
NO (1) NO309266B1 (no)
PL (1) PL183210B1 (no)
PT (1) PT788480E (no)
WO (1) WO1996012699A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
BRPI0104491B8 (pt) * 2001-10-10 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ATE482695T1 (de) 2002-12-13 2010-10-15 Durect Corp Orale darreichungsform mit flüssigen hochviskosen trägersystemen
US7094812B2 (en) * 2003-04-24 2006-08-22 Xerox Corporations Colorant compositions
US6790267B1 (en) * 2003-04-24 2004-09-14 Xerox Corporation Colorant compositions
RS52198B (en) 2004-09-17 2012-10-31 Durect Corporation LOCAL ANESTHETIC SOLUTION CONTAINING SAIB SUSTAINABLE ACTION
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US20090187024A1 (en) * 2006-04-25 2009-07-23 Dishman Pharmaceuticals And Chemicals Ltd. Ropivacaine hydrochloride anhydrate and the preparation thereof
US8337883B2 (en) 2006-11-03 2012-12-25 Durect Corporation Transdermal delivery systems
CA2706658A1 (en) 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition
ES2383714T3 (es) * 2008-01-15 2012-06-25 Pharmathen S.A. Proceso para preparar un compuesto (S)-1-alquil-2',6'-pipecoloxilidídico
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN103073484B (zh) * 2013-01-28 2014-10-22 山东诚创医药技术开发有限公司 一种甲哌卡因及其光学对映体的制备方法
AU2014233453A1 (en) 2013-03-15 2015-10-01 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
KR102442753B1 (ko) * 2016-12-26 2022-09-16 셀릭스 바이오 프라이빗 리미티드 만성 통증 치료를 위한 화합물
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE341404B (no) * 1967-05-18 1971-12-27 Sterling Drug Inc
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide

Also Published As

Publication number Publication date
AU3704895A (en) 1996-05-15
ES2202375T3 (es) 2004-04-01
DE69531356T2 (de) 2004-05-27
JPH10507464A (ja) 1998-07-21
EP0788480B1 (en) 2003-07-23
HU227420B1 (en) 2011-05-30
HUT77631A (hu) 1998-06-29
NO971903D0 (no) 1997-04-24
WO1996012699A1 (en) 1996-05-02
PL183210B1 (pl) 2002-06-28
FI971711A0 (fi) 1997-04-22
MX9703024A (es) 1997-10-31
CA2200355A1 (en) 1996-05-02
FI117438B (fi) 2006-10-13
PL319829A1 (en) 1997-09-01
PT788480E (pt) 2003-12-31
DE69531356D1 (de) 2003-08-28
CA2200355C (en) 2007-03-06
AU698637B2 (en) 1998-11-05
DK0788480T3 (da) 2003-09-29
FI971711L (fi) 1997-04-22
NO309266B1 (no) 2001-01-08
JP3911545B2 (ja) 2007-05-09
ATE245629T1 (de) 2003-08-15
EP0788480A1 (en) 1997-08-13
US5994548A (en) 1999-11-30

Similar Documents

Publication Publication Date Title
NO971903D0 (no) Krystallisering av levobupivacain og analoger derav
DE69200983D1 (de) Verfahren zur Herstellung von Wasserstoffsuperoxyd.
ES8705387A1 (es) Un procedimiento para preparar derivados de n-aril-n-(4-piperidinil)-alcoxialquilamida
DK0581959T3 (da) Anvendelse af makrolidforbindelser til øjensygdomme
DE69204484D1 (de) Verfahren zur Herstellung von Wasserstoffperoxyd.
DE69307509D1 (de) Vorrichtung zur behandlung von herzfehlern
NO308397B1 (no) Desinfiseringsmiddelblanding, fremgangsmÕte for fremstilling derav og anvendelse av denne, samt to-pakkesystem
DE59209922D1 (de) Thrombin sowie Verfahren zu seiner Herstellung
ATE153022T1 (de) 3',5'-ditertbutyl-4'-hydroxyflavone, verfahren zu ihrer herstellung und pharmazeutische zusammensetzung mit antioxidations- und antivasokonstriktionsaktivität
DK0788481T3 (da) Fremgangsmåde til fremstilling af levobupivacain og analoger deraf
PT638075E (pt) Inibidor da reaccao de maillard
ATE86978T1 (de) Verfahren zur herstellung von 3,5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer.
ATE81976T1 (de) 2-pyrimidinyl-1-piperazin-derivate zur behandlung von alkoholismus.
DE69202680D1 (de) Verfahren zur Herstellung von Wasserstoffperoxyd.
PT83309B (de) Neue pyrrolo-benzimidazole pyrrolo-benzoxazole und pyrrolo-benzthiazole verfahren zu ihrer herstellung und diese verbindungen enthaltende arneimittel
DK0821588T3 (da) Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder
NO884447L (no) Fremgangsmaate for maling under vann og anordning for paafoering av malingen.
DE59105224D1 (de) Verfahren zur Herstellung von N-substituierten Pyrrolidonen.
ATE69795T1 (de) Verfahren zur herstellung von ethylenischen carbonylverbindungen.
DE59407675D1 (de) Verfahren zur Herstellung von 6H-Dibenz-(c,e)(1,2)-oxaphosphorin-6-on
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
FI954138A0 (fi) Hydroksimetyylifuratsaanikarboksyylihappojohdannaiset ja niiden käyttö sydänverisuonitautien käsittelyssä
DE69210933D1 (de) Verfahren zur Herstellung von Alpha, Omega-Dihydroxyperfluoroalkylethylmethylpolysiloxanen
DE69103913D1 (de) Verfahren zur Herstellung von Dodekandicarbonsäure.
NO881414L (no) Fremgangsmaate for behandling av spillvann og annet urent vann.

Legal Events

Date Code Title Description
MK1K Patent expired